Relypsa to Present at 36th Annual Cowen Health Care Conference
Mar 01, 2016 13:30 pm UTC| Business
REDWOOD CITY, Calif., March 01, 2016 -- Relypsa, Inc. (Nasdaq:RLYP) today announced that John A. Orwin, president and chief executive officer, will present at the 36th Annual Cowen Health Care Conference on March 8,...
Aqua Metals Attending Upcoming Investor Conferences in March
Mar 01, 2016 13:30 pm UTC| Business
ALAMEDA, Calif., March 01, 2016 -- Aqua Metals, Inc. (NASDAQ:AQMS) ("Aqua Metals" or the "Company"), which is commercializing a non-pollutive electrochemical lead recycling technology called AquaRefining™, will be...
Pacific Ethanol Retires $17 Million in Plant Term Debt
Mar 01, 2016 13:30 pm UTC| Business
SACRAMENTO, Calif., March 01, 2016 -- Pacific Ethanol, Inc. (NASDAQ:PEIX), a leading producer and marketer of low-carbon renewable fuels in the United States, announced it has paid in cash and retired the remaining...
Amyris Biossance™ Brand Launches The Purifier ─ a Unique Soothing Cleansing Oil
Mar 01, 2016 13:30 pm UTC| Business
EMERYVILLE, Calif., March 01, 2016 -- Biossance™, the pioneer of sustainable solutions in beauty from Amyris, Inc. (Nasdaq:AMRS), has introduced The Purifier Soothing Cleansing Oil, the newest addition to its...
Global Ship Lease Reports Results for the Fourth Quarter of 2015
Mar 01, 2016 13:30 pm UTC| Business
LONDON, March 01, 2016 -- Global Ship Lease, Inc. (NYSE:GSL) (the “Company”), a containership charter owner, announced today its unaudited results for the three months and year ended December 31, 2015. Fourth Quarter...
GWG Holdings to Present at the 28th Annual ROTH Conference
Mar 01, 2016 13:30 pm UTC| Business
MINNEAPOLIS, March 01, 2016 -- GWG Holdings, Inc.(NASDAQ:GWGH) ("GWG" or “the Company”), a specialty finance company and leader in the life insurance secondary market, announced today that the Company will be presenting...
Ultragenyx Announces Data Presentations of rhGUS and rhPPCA at 12th Annual WORLD Symposium™
Mar 01, 2016 13:30 pm UTC| Business
NOVATO, Calif., March 01, 2016 -- Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today announced upcoming...